BMJ 2008;336:1062-1066 (10 May), doi:10.1136/bmj.39547.603218.AE
Clinical Review
Medical management of Crohns disease
J R Fraser Cummings, specialist registrar,
Satish Keshav, consultant gastroenterologist,
Simon P L Travis, consultant gastroenterologist
1 Gastroenterology Unit, John Radcliffe Hospital, Oxford OX3 9DU
Correspondence to: S P L Travis simon.travis@ndm.ox.ac.uk
| The first 150 words of the full text of this article appear below. |
- Biological therapies have radically changed the management of Crohns disease but must be used judiciously with great awareness of possible adverse events
- Treatment strategies for the disease are rapidly evolving, with immunomodulator and biological therapy being considered in patients who have indicators for developing early severe disease
- Clinical indicators of a poor prognosis (at diagnosis) include perianal or stricturing disease, weight loss >5 kg, or the need for steroids
- Treatment of active disease with mesalazine is little better than placebo; mesalazine is used mainly to reduce the risk of relapse after small intestinal resection
- Access to specialist services, parallel medical and surgical clinics, nurse specialists, dietitians, pharmacists, and other allied professionals is as important as the medication
- Publication of standards of care should drive improvement in the care and provision of resources for patients with Crohns disease
| |
Crohns disease is a chronic, relapsing and remitting inflammatory condition of the gastrointestinal . . . [Full text of this article]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Rapid Responses:
Read all Rapid Responses
- Non-invasive markers in Crohn’s
- Mohammed A Butt, et al.
bmj.com, 13 May 2008
[Full text]
- Antibodies in inflammatory bowel disease
- Mohammed A Butt, et al.
bmj.com, 13 May 2008
[Full text]
- Crohn's disease
- GEORGE Y CALDWELL, et al.
bmj.com, 14 May 2008
[Full text]
- Remember lymphogranuloma venereum
- Kinesh P Patel, et al.
bmj.com, 3 Jun 2008
[Full text]